Omeros Corp. (OMER) News Headlines

▮ More

Date

Headline

5/24/2018 7:03:06 AM Omeros Announces Settlement Of Infringement Suit Against ANDA Filer Lupin

5/14/2018 10:10:09 PM ALL Eyes On PRPH, TNDM Soars On Analyst Upgrade, OMER Back In Focus

5/1/2018 3:35:57 PM Wedbush Reiterates Omeros Corp. (OMER) At Neutral With $19 Price Target

3/26/2018 11:22:15 PM DXR Continues To Slide, Keep An Eye On ASNS, Data Fails To Propel PTGX

3/23/2018 7:31:05 AM Wedbush Is Lowering Omeros Corp. (OMER) FY18 Rev. Estimate To 9.5 M From 121.5 M

3/23/2018 7:30:40 AM Wedbush Is Cutting Omeros Corp. (OMER) Q4 18 Rev. Estimate To 3.4 M From 36.1 M

3/23/2018 7:30:28 AM Wedbush Is Lowering Omeros Corp. (OMER) Q3 18 Rev. Estimate To 2.6 M From 31.5 M

3/23/2018 7:29:47 AM Wedbush Is Lowering Omeros Corp. (OMER) Q2 18 Rev. Estimate To 2.0 M From 28.6 M

3/23/2018 7:29:13 AM Wedbush Is Lowering Omeros Corp. (OMER) Q1 19 Rev. Estimate To 1.5 M From 25.3 M

3/23/2018 7:28:36 AM Wedbush Is Lowering Omeros Corp. (OMER) FY18 Estimate To -2.03 From -0.24

3/23/2018 7:28:07 AM Wedbush Is Lowering Omeros Corp. (OMER) Q4 18 Estimate To -0.50 From 0.02

3/23/2018 7:27:51 AM Wedbush Is Lowering Omeros Corp. (OMER) Q3 18 Estimate To -0.51 From -0.05

3/23/2018 7:27:37 AM Wedbush Is Cutting Omeros Corp. (OMER) Q2 18 Estimate To -0.52 From -0.09

3/23/2018 7:27:16 AM Wedbush Is Cutting Omeros Corp. (OMER) Q1 18 Estimate To -0.51 From -0.13

3/23/2018 7:26:03 AM Wedbush Lowers Omeros Corp. (OMER) To Neutral From Outperform With $19 Down From $47 Price Target

3/22/2018 9:24:03 PM OMER Back In Focus, INNT Moving Ahead, Keep An Eye On EARS

2/22/2018 11:28:07 PM ADXS Falls On Stock Offering, OMER Down 36% In 5 Days, Analyst Downgrades ALKS

2/15/2018 7:43:13 AM Omeros Announced New Results From Ongoing Phase 2 Study Of OMS721

1/22/2018 7:04:25 AM EMA Issues Orphan Drug Designation Positive Opinion For Omeros’ OMS721 In The Treatment Of IgA Nephropathy

1/4/2018 7:42:45 AM Wedbush Reiterates Omeros Corp. (OMER) At Outperform With $47 Price Target